Drug Pipeline

AVTX-803 (L-Fucose) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-14 NCT07432490
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency…		 Recruitment opened
2026-05-14 NCT07432490
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency…		 date change Primary completion pushed: 2027-05 -> 2027-07
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05462587 A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion… Leukocyte Adhesion Deficiency Recruiting
NCT05754450 An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With… Leukocyte Adhesion Deficiency Recruiting
Phase 2
NCT07432490 A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency… Glut1 Deficiency Recruiting
Sponsors Running AVTX-803 (L-Fucose) Trials
AUG Therapeutics (2) Oregon Health and Science University (1)
Get alerts when AVTX-803 (L-Fucose) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free